Robert Lisicki
CIK 1779614 · Chief Executive Officer · last filed 2025-03-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ARNA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
6154 NANCY RIDGE DRIVE
SAN DIEGO, CA 92121
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZURA | Chief Executive Officer | — | $4.07 | — | $0 | 2 | 2025-03-03 |
| CVKD | Director | — | $0.96 | — | $0 | 3 | 2025-01-24 |
| Zura Bio Ltd (ZURAW) Delisted | Chief Executive Officer | — | $1.08 | — | $0 | 2 | 2024-06-21 |
| ARENA PHARMACEUTICALS INC (ARNA) Delisted | EVP, Chief Commercial Officer | 0 | $99.99 | $0 | -$4.79M | 13 | 2022-03-11 |
Recent Filings · Page 2 of 2
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-03 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Grant (A) | +6,660 | $0 | EDGAR |
| 2021-02-04 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Mixed | — | -$663.7K | EDGAR |
| 2021-02-04 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | — | — | $0 | EDGAR |
| 2021-01-11 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Mixed | +9,441 | -$245.1K | EDGAR |
| 2020-12-03 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Sell (S) | −3,872 | -$255.8K | EDGAR |
| 2020-11-30 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Mixed | +3,872 | -$159.0K | EDGAR |
| 2020-08-06 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Mixed | — | -$671.8K | EDGAR |
| 2020-03-03 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-11-26 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Sell (S) | −4,429 | -$203.0K | EDGAR |
| 2019-10-16 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Mixed | +4,429 | -$88.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.